Eculizumab And Ahus Patients
EDM number 622 in 2014-15, proposed by Keith Vaz on 11/12/2014.
Categorised under the topics of Diseases and Health services.
That this House applauds the decision by the National Institute for Health and Care Excellence to recommend that the drug eculizumab be used for treating atypical haemolytic uraemic syndrome (aHUS); notes that this life-threatening disease affects around 200 people in England with 20 to 30 new patients diagnosed with the condition each year; and recognises that a petition of 30,000 signatures was presented to the House calling for the use of this drug.
This motion has been signed by a total of 24 MPs.
Download raw data as csv or xml.